AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 1 filers reported holding AXOVANT GENE THERAPIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,122,000 | +29.6% | 1,325,000 | -20.9% | 0.09% | +9.6% |
| Q2 2020 | $4,723,000 | +43.4% | 1,675,000 | +24.1% | 0.08% | 0.0% |
| Q1 2020 | $3,294,000 | +8.5% | 1,350,000 | +127.6% | 0.08% | +22.1% |
| Q4 2019 | $3,037,000 | -5.0% | 593,216 | +19.8% | 0.07% | -22.7% |
| Q3 2019 | $3,198,000 | -6.7% | 495,000 | -10.0% | 0.09% | +11.4% |
| Q2 2019 | $3,427,000 | – | 550,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|